australian alzheimer drugs market

Australian Alzheimer Drugs Market: Segmented by Drug Class (Cholinergic, Memantine, Combined Drug, & Others), by Distribution (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, & Others)- Growth, Trends, and Forecasts (2019 2028)

  • Published Date: 2022-12-28
  • Report ID: 140014
  • Pages: 200
  • Format: prudent report format

Report Overview

The Australian Alzheimer drug market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Alzheimers disease is the most common form of dementia, affecting up to 70% of all people with dementia. Alzheimers disease can be eithersporadicorfamilial. SporadicAlzheimer's disease can affect adults at any age, but usually occurs after age 65 and is the most common form of Alzheimer's disease. FamilialAlzheimers disease is a very rare genetic condition, caused by a mutation in one of several genes. The presence of mutated genes means that the person will eventually develop Alzheimer's disease, usually in their 40's or 50's.



Market Drivers

The main driver of this impressive growth, which will occur across Australia will be rising and aging populations, like Alzheimer's disease, is significantly more prevalent among the elderly. The population above 60 years of age forms the target demographic segment for this vertical, as this population subset is more prone to neurological conditions. The advancement of diagnostics equipment increases the lifespan of this demographic and improves the quality of life for those suffering from neurological conditions. Hence, the presence of a large geriatric population pool is considered a vital driver for this industry.

Additional market drivers include better diagnostic techniques, improving health awareness, special healthcare programs, health insurance coverage, and increasing treatment affordability.

Major Alzheimer Diseases

Based on disease indication, the Alzheimer Diseases market can be segmented into late-onset: which happens to people age 65 and older, early-onset: affect people in their 30s or 40s, and familial: before the age of 65 (usually between 30 and 60 years of age) and is inherited in an autosomal dominant fashion. In the final stage of the disease, dementia symptoms are severe. Individuals lose the ability to respond to their environment, to carry on a conversation, and eventually, to control movement.


1. Australian Alzheimer Drugs Market Overview...........................................
A. Market Size
2. Market Growth Drivers..
A. Rise in Prevalence of Alzheimer Drugs
B. Increase in Geriatric Population
C. Growing R&D Investments and Reimbursement Policies
3. Major Alzheimer Diseases..
A. Late-Onset
B. Early Onset
C. Familial
4. Alzheimer Drugs Market Segmentation........................
A. Drug Class
I. Cholinergic
II. Memantine
III. Combined Drug
IV. Others
B. Distribution
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
IV. Others
5. Alzheimer Drugs Major Products Market Share.
A. Market Analysis, Insights and Forecast By Revenue
6. Competitive Landscape......
A. Major Players
B. Products in Pipeline
7. Key Company Profiles.
A. F. Hoffmann-La Roche Diagnostics overview, Product & Services, Strategies & Financials
B. Biogen overview, Product & Services, Strategies & Financials
C. GE Healthcare overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth
A. New Trends and Development of Alzheimer Drugs Market
B. Future Opportunities
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.